Item 16. Form 10-K Summary.
6K characters. Original on sec.gov ·
Item 16. Form 10-K Summary.
The optional summary in Item 16 has not been included in this Form 10-K.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| MASCO CORPORATION | ||||||||
| By: | /s/ Richard J. Westenberg | |||||||
| Richard J. Westenberg Vice President, Chief Financial Officer and Treasurer |
February 10, 2026
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated.
| Principal Executive Officer: | ||||||||||||||
| /s/ Jonathon J. Nudi | President and Chief Executive Officer and Director | |||||||||||||
| Jonathon J. Nudi | ||||||||||||||
| Principal Financial Officer: | ||||||||||||||
| /s/ Richard J. Westenberg | Vice President, Chief Financial Officer and Treasurer | |||||||||||||
| Richard J. Westenberg | ||||||||||||||
| Principal Accounting Officer: | ||||||||||||||
| /s/ Heath M. Eisman | Vice President, Controller and Chief Accounting Officer | |||||||||||||
| Heath M. Eisman | ||||||||||||||
| /s/ Lisa A. Payne | Chair of the Board | |||||||||||||
| Lisa A. Payne | ||||||||||||||
| /s/ Mark R. Alexander | Director | |||||||||||||
| Mark R. Alexander | ||||||||||||||
| /s/ Gary A. Coombe | Director | |||||||||||||
| Gary A. Coombe | ||||||||||||||
| /s/ Aine L. Denari | Director | |||||||||||||
| Aine L. Denari | ||||||||||||||
| /s/ Marie A. Ffolkes | Director | |||||||||||||
| Marie A. Ffolkes | ||||||||||||||
| /s/ Christopher A. O'Herlihy | Director | |||||||||||||
| Christopher A. O'Herlihy | ||||||||||||||
| /s/ John C. Plant | Director | |||||||||||||
| John C. Plant | ||||||||||||||
| /s/ Sandeep Reddy | Director | |||||||||||||
| Sandeep Reddy | ||||||||||||||
| /s/ Charles K. Stevens, III | Director | |||||||||||||
| Charles K. Stevens, III | ||||||||||||||
| February 10, 2026 |
MASCO CORPORATION
SCHEDULE II. VALUATION AND QUALIFYING ACCOUNTS
For the Years Ended December 31, 2025, 2024 and 2023
| (In Millions) | ||||||||||||||||||||||||||||||||||||||
| Column A | Column B | Column C | Column D | Column E | ||||||||||||||||||||||||||||||||||
| Additions | ||||||||||||||||||||||||||||||||||||||
| Description | Balance at Beginning of Period | Charged to Costs and Expenses | Charged to Other Accounts | Deductions | Balance at End of Period | |||||||||||||||||||||||||||||||||
| Allowances for credit losses deducted from accounts receivable in the balance sheet: | ||||||||||||||||||||||||||||||||||||||
| 2025 | $ | 10 | $ | 5 | $ | — | $ | (4) | (a) | $ | 12 | |||||||||||||||||||||||||||
| 2024 | $ | 11 | $ | 4 | $ | — | $ | (5) | (a) | $ | 10 | |||||||||||||||||||||||||||
| 2023 | $ | 8 | $ | 7 | $ | — | $ | (5) | (a) | $ | 11 | |||||||||||||||||||||||||||
| Valuation allowance on deferred tax assets: | ||||||||||||||||||||||||||||||||||||||
| 2025 | $ | 27 | $ | — | $ | — | $ | — | $ | 27 | ||||||||||||||||||||||||||||
| 2024 | $ | 33 | $ | — | $ | — | $ | (6) | (b) | $ | 27 | |||||||||||||||||||||||||||
| 2023 | $ | 15 | $ | 2 | $ | 53 | (c)(d) | $ | (37) | (e) | $ | 33 |
______________________________
**(a)**Deductions, representing uncollectible accounts written off and divestitures, less recoveries of accounts written off in prior years.
**(b)**Primarily other activity not affecting income tax expense.
**(c)**As a result of the acquisition of Sauna360 Group Oy in the third quarter of 2023, $5 million was added to valuation allowance on deferred tax assets.
(d)$48 million was added to valuation allowance resulting from the establishment of certain state deferred tax assets for which the likelihood of utilization is no longer considered remote.
**(e)**Due to a legal restructuring of certain U.S. businesses that occurred in early 2024, a $37 million reduction in valuation allowance was recorded as a $29 million state income tax benefit, net of federal expense.
Previous: Item 15. Exhibits and Financial Statement Schedules.